UNSPSC 51313109: Buclizine dihydrochloride

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51313109

Definition

This classification denotes a histamine-1 receptor antagonist with the molecular formula C28H33ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58FQD093NU, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, but more generally known as buclizine dihydrochloride, which bears US NIH Compound Identifier 6729.

European Medicines Agency schedules buclizine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05947MIG. Most nations, for tariff purposes, schedule buclizine dihydrochloride under HS 29335995. SMILES: CC(C)(C)C1CCC(CC1)CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.

About UNSPSC 51313109

UNSPSC 51313109 Buclizine dihydrochloride, a Commodity code, nominally covers a specific antihistamine pharmaceutical. However, the recent state and local procurement activity tagged to this code does not align with buclizine purchases. The single available opportunity from the past year—Seminole County, Florida's IFB 60459723LAS—solicits naloxone (an opioid antagonist) and safe drug deactivation systems in volume, with no reference to buclizine or related antihistamines. The mismatch suggests either a data-tagging error in the source system or a rare and narrow use case for buclizine within a broader emergency-response or harm-reduction procurement. State and local governments buying under this code, if activity aligns with the nominal commodity, would typically be county health departments, municipal public health offices, or special-purpose health authorities acquiring pharmaceutical inventory for clinical or community-health programs.

Seminole County's naloxone and drug deactivation systems bid (due July 26, 2023) represents the only indexed recent opportunity, requiring 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB specified fixed-fee pricing, E-Verify compliance, standard insurance coverage, and a two-year initial term with optional one-year renewal. Vendors were required to submit bids electronically with shipping included in proposals. The procurement carried no explicit set-aside designations and noted potential FEMA funding with associated federal compliance requirements. Beyond Florida, the code shows little indexed recent activity, and the single Seminole County opportunity suggests minimal current state and local procurement volume under this specific commodity code.

Quick answers

What is UNSPSC 51313109?

UNSPSC 51313109 is Buclizine dihydrochloride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51313109?

UNSPSC 51313109 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51313109

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code